DNKClass II
Thin Layer Chromatography, Morphine
21 CFR 862.3640 / Clinical Toxicology
DNK is the FDA product code for Thin Layer Chromatography, Morphine, a class II device type, regulated under 21 CFR 862.3640. As of , FDA records hold 4 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- DNK
- Device name
- Thin Layer Chromatography, Morphine
- Regulation
- 21 CFR 862.3640
- Device class
- Class II
- Review panel
- Clinical Toxicology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 4
- Ingested recalls
- 0
Clearances, product code DNK
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1986 | 1 |
| 1997 | 1 |
| 2015 | 2 |
Applicants with the most clearances
Product code DNK| Applicant | Clearances |
|---|---|
| Guangzhou Wondfo Biotech Co., Ltd. | 1 |
| Medical Diagnostics, Ca. | 1 |
| Nantong Egens Biotech Co., Ltd. | 1 |
| Teco Diagnostics | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
